Sector Update: Healthcare

By
A A A

Healthcare shares are generally lower in pre-market trade.

Vertex ( VRTX ) shares are down 4% after it said data from a Phase 3 study of ivacaftor in 69 people 6 years of age and older with cystic fibrosis ( CF ) who have the R117H mutation did not meet the company's primary endpoint.

And, pSivida Corp. ( PSDV ) late yesterday said its licensee Alimera Sciences ( ALIM ) has entered into labeling discussions with the U.S. Food and Drug Administration (FDA) for ILUVIEN.

PSDV is up 64% at $4.87 pre-market; ALIM is up 101% at $5.14. As a result, both companies' participation in the January 2014 Dermatologic and Ophthalmic Advisory Committee meeting is no longer necessary.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: ALIM , CF , PSDV , VRTX

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Quick on Your Feet
Quick on Your Feet                  
Early Entrepreneurship
Early Entrepreneurship              

Stocks

Referenced

Most Active by Volume

48,099,947
  • $16.09 ▲ 0.50%
40,277,806
  • $102.50 ▲ 0.24%
40,236,499
  • $19.57 ▲ 2.35%
31,092,510
  • $49.75 ▲ 0.65%
30,795,218
  • $34.92 ▲ 0.78%
29,910,855
  • $3.63 ▲ 0.83%
24,019,154
  • $13.06 ▼ 0.38%
23,753,906
  • $74.82 ▲ 1.31%
As of 8/29/2014, 04:04 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com